Literature DB >> 20029553

[Liver transplantation in Norway through 25 years].

Tim Scholz1, Tom H Karlsen, Truls Sanengen, Erik Schrumpf, Pal Dag Line, Kirsten Muri Boberg, Pal Foyn Jörgensen, Bjarte Fosby, Oystein Bentdal, Anniken Björnstad Ostensen, Svein Osnes, Fridtjov Riddervold, Hakon Haugaa, Jon Hausken, Jon Bragi Bergmann, Stein Foss, Kristian Björo, Aksel Foss.   

Abstract

BACKGROUND: In Norway, liver transplantation has been the treatment of choice for irreversible acute and chronic liver failure for 25 years. The aim of this article is to present a summary of the results obtained.
MATERIAL AND METHODS: All liver transplants performed in Norway in the period 25.02.84-31.12.08 have been reviewed retrospectively with respect to patient and donor epidemiology, survival and recurrence.
RESULTS: 651 transplants have been performed in this period. The annual number of transplants increased gradually up to the year 2000 (31), and more steeply afterwards - to 79 in 2008. Also the number of organ donations has increased and reached 98 (20 pr. million inh.) in 2008. 5-year patient survival was 53 % in the period 1984-1994. In the period 2001-2008, 1-year survival was 90 % and 5-year survival was 83 %.
INTERPRETATION: The gradual improvement of results should be interpreted in light of improvements within transplant surgery, medicine and anaesthesiology and the increased local experience due to the increasing number of transplants performed. The transplant centre at Rikshospitalet has developed into being among the largest of its kind within the Nordic Countries and the results compare well with the best international data.

Entities:  

Mesh:

Year:  2009        PMID: 20029553     DOI: 10.4045/tidsskr.09.1106

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  3 in total

Review 1.  Liver transplantation in treatment of colorectal liver metastases.

Authors:  Morten Hagness
Journal:  Hepat Oncol       Date:  2015-04-27

2.  Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis.

Authors:  Peder Rustøen Braadland; Kai Markus Schneider; Annika Bergquist; Antonio Molinaro; Anita Lövgren-Sandblom; Marcus Henricsson; Tom Hemming Karlsen; Mette Vesterhus; Christian Trautwein; Johannes Roksund Hov; Hanns-Ulrich Marschall
Journal:  JHEP Rep       Date:  2022-08-18

3.  Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway.

Authors:  Ina M Andersen; Bjarte Fosby; Kirsten M Boberg; Ole P F Clausen; Peter Jebsen; Espen Melum; Pål D Line; Aksel Foss; Erik Schrumpf; Tom H Karlsen
Journal:  Transplant Direct       Date:  2015-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.